The essential consequences of polymorphism in the pharmaceutical field
Polymorphism. Basic principles and characterization methods
Article REF: P1098 V2
The essential consequences of polymorphism in the pharmaceutical field
Polymorphism. Basic principles and characterization methods

Author : Michel BAUER

Publication date: November 10, 2022 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

1. The essential consequences of polymorphism in the pharmaceutical field

1.1 Polymorphism/dissolution kinetics and bioavailability

Most drugs are still prescribed orally in solid form (tablets, capsules, suspensions). Once in the stomach, the galenic form undergoes a disintegration process, gradually releasing the active ingredient throughout the gastrointestinal tract. The active ingredient then passes into solution in a molecular state. It can then diffuse towards the intestinal cell wall. Through a process of permeation, the active molecule passes through the cellular system into the bloodstream, where it can reach its site(s) of action (figure 1...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Analysis and Characterization"

( 256 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details